Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy

BACKGROUND: Oxaliplatin is a chemotherapy agent active against digestive tumors. Peripheral neuropathy is one of the most important dose-limiting toxicity of this drug. It occurs in around 60–80% of the patients, and 15% of them develop severe neuropathy. The pathophysiology of oxaliplatin neurotoxi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Cancer
Hlavní autoři: Sereno, María, Gutiérrez-Gutiérrez, Gerardo, Rubio, Juan Moreno, Apellániz-Ruiz, María, Sánchez-Barroso, Lara, Casado, Enrique, Falagan, Sandra, López-Gómez, Miriam, Merino, María, Gómez-Raposo, César, Rodriguez-Salas, Nuria, Tébar, Francisco Zambrana, Rodríguez-Antona, Cristina
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2017
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5248487/
https://ncbi.nlm.nih.gov/pubmed/28103821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-3031-5
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky